Literature DB >> 7050152

Use of potato flakes agar in clinical mycology.

M G Rinaldi.   

Abstract

A formulation comprised of commercially available potato flakes, glucose, and agar provides a medium which is inexpensive, is easily prepared, and is particularly useful for the identification of mold fungi encountered in the clinical mycology laboratory. The inclusion of appropriate antimicrobial agents results in a selective medium effective in the isolation and identification of medically important fungi.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7050152      PMCID: PMC272272          DOI: 10.1128/jcm.15.6.1159-1160.1982

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  3 in total

1.  The spectrum of opportunistic fungus infections.

Authors:  J P UTZ
Journal:  Lab Invest       Date:  1962-11       Impact factor: 5.662

2.  Pathogenesis and epidemiology of opportunistic mycotic infections: a review.

Authors:  J W Rippon
Journal:  Am J Med Technol       Date:  1977-03

3.  Aspergillosis and other systemic mycoses. The growing problem.

Authors:  D W Fraser; J I Ward; L Ajello; B D Plikaytis
Journal:  JAMA       Date:  1979-10-12       Impact factor: 56.272

  3 in total
  41 in total

1.  In vitro activities of approved and investigational antifungal agents against 44 clinical isolates of basidiomycetous fungi.

Authors:  G M González; D A Sutton; E Thompson; R Tijerina; M G Rinaldi
Journal:  Antimicrob Agents Chemother       Date:  2001-02       Impact factor: 5.191

2.  Correlation between antifungal susceptibilities of Coccidioides immitis in vitro and antifungal treatment with caspofungin in a mouse model.

Authors:  G M González; R Tijerina; L K Najvar; R Bocanegra; M Luther; M G Rinaldi; J R Graybill
Journal:  Antimicrob Agents Chemother       Date:  2001-06       Impact factor: 5.191

3.  A pseudo-outbreak of Methylobacterium mesophilica isolated from patients undergoing bronchoscopy.

Authors:  D J Flournoy; R L Petrone; D W Voth
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1992-03       Impact factor: 3.267

4.  Comparison of oral fluconazole and clotrimazole troches as treatment for oral candidiasis in patients infected with human immunodeficiency virus.

Authors:  S L Koletar; J A Russell; R J Fass; J F Plouffe
Journal:  Antimicrob Agents Chemother       Date:  1990-11       Impact factor: 5.191

5.  Cutaneous infection caused by Macrophomina phaseolina in a child with acute myeloid leukemia.

Authors:  Ashok Srinivasan; Brian L Wickes; Anna M Romanelli; Larisa Debelenko; Jeffrey E Rubnitz; Deanna A Sutton; Elizabeth H Thompson; Annette W Fothergill; Michael G Rinaldi; Randall T Hayden; Jerry L Shenep
Journal:  J Clin Microbiol       Date:  2009-04-22       Impact factor: 5.948

6.  An aberrant variant of Histoplasma capsulatum var. capsulatum.

Authors:  D A Sutton; A A Padhye; P G Standard; M G Rinaldi
Journal:  J Clin Microbiol       Date:  1997-03       Impact factor: 5.948

7.  Sequence-based identification of filamentous basidiomycetous fungi from clinical specimens: a cautionary note.

Authors:  Anna M Romanelli; Deanna A Sutton; Elizabeth H Thompson; Michael G Rinaldi; Brian L Wickes
Journal:  J Clin Microbiol       Date:  2009-12-30       Impact factor: 5.948

8.  Susceptibilities of clinical and laboratory isolates of Blastomyces dermatitidis to ketoconazole, itraconazole, and fluconazole.

Authors:  S W Chapman; P D Rogers; M G Rinaldi; D C Sullivan
Journal:  Antimicrob Agents Chemother       Date:  1998-04       Impact factor: 5.191

9.  Human phaeohyphomycotic osteomyelitis caused by the coelomycete Phomopsis saccardo 1905: criteria for identification, case history, and therapy.

Authors:  D A Sutton; W D Timm; G Morgan-Jones; M G Rinaldi
Journal:  J Clin Microbiol       Date:  1999-03       Impact factor: 5.948

10.  Disseminated Microascus cirrosus infection in pediatric bone marrow transplant recipient.

Authors:  K K Krisher; N B Holdridge; M M Mustafa; M G Rinaldi; D A McGough
Journal:  J Clin Microbiol       Date:  1995-03       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.